SN vs. HLN, SGE, WHR, ANP, CLX, TPX, PNPL, LEG, ULVR, and NIOX
Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include Haleon (HLN), The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), Unilever (ULVR), and NIOX Group (NIOX).
Smith & Nephew vs. Its Competitors
Smith & Nephew (LON:SN) and Haleon (LON:HLN) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.
Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.6%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.6%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 50.5% of its earnings in the form of a dividend.
In the previous week, Haleon had 2 more articles in the media than Smith & Nephew. MarketBeat recorded 3 mentions for Haleon and 1 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 0.00 beat Haleon's score of -0.74 indicating that Smith & Nephew is being referred to more favorably in the media.
Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.
62.2% of Smith & Nephew shares are owned by institutional investors. Comparatively, 43.9% of Haleon shares are owned by institutional investors. 0.2% of Smith & Nephew shares are owned by insiders. Comparatively, 10.7% of Haleon shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Smith & Nephew has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500.
Smith & Nephew currently has a consensus price target of GBX 7,840, indicating a potential upside of 609.50%. Haleon has a consensus price target of GBX 457, indicating a potential upside of 22.49%. Given Smith & Nephew's higher possible upside, analysts clearly believe Smith & Nephew is more favorable than Haleon.
Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.
Summary
Smith & Nephew beats Haleon on 9 of the 17 factors compared between the two stocks.
Get Smith & Nephew News Delivered to You Automatically
Sign up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Smith & Nephew Competitors List
Related Companies and Tools
This page (LON:SN) was last updated on 7/3/2025 by MarketBeat.com Staff